As Johnson & Johnson (JNJ) Market Value Declined, Korea Investment Has Lifted Its Position; First Trust Advisors LP Upped Position in Timken Co (TKR) by $3.13 Million

May 18, 2018 - By Louis Casey

Johnson & Johnson (NYSE:JNJ) Logo

First Trust Advisors Lp increased its stake in Timken Co (TKR) by 55.43% based on its latest 2017Q4 regulatory filing with the SEC. First Trust Advisors Lp bought 63,906 shares as the company’s stock declined 8.81% with the market. The institutional investor held 179,198 shares of the metal fabrications company at the end of 2017Q4, valued at $8.81 million, up from 115,292 at the end of the previous reported quarter. First Trust Advisors Lp who had been investing in Timken Co for a number of months, seems to be bullish on the $3.84B market cap company. The stock increased 1.29% or $0.63 during the last trading session, reaching $49.45. About 510,025 shares traded. The Timken Company (NYSE:TKR) has risen 3.73% since May 18, 2017 and is uptrending. It has underperformed by 7.82% the S&P500.

Korea Investment Corp increased its stake in Johnson & Johnson (JNJ) by 4.01% based on its latest 2017Q4 regulatory filing with the SEC. Korea Investment Corp bought 84,200 shares as the company’s stock declined 9.21% with the market. The institutional investor held 2.18 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $305.23M, up from 2.10 million at the end of the previous reported quarter. Korea Investment Corp who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $332.18B market cap company. The stock decreased 1.20% or $1.5 during the last trading session, reaching $123.85. About 6.47M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 18, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Among 10 analysts covering The Timken Company (NYSE:TKR), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. The Timken Company had 26 analyst reports since August 3, 2015 according to SRatingsIntel. Jefferies maintained The Timken Company (NYSE:TKR) on Wednesday, April 19 with “Hold” rating. The firm has “Outperform” rating given on Monday, July 11 by Avondale. The firm earned “Hold” rating on Wednesday, June 28 by Stifel Nicolaus. The rating was initiated by Topeka Capital Markets on Thursday, May 26 with “Hold”. The firm earned “Buy” rating on Thursday, April 28 by Stifel Nicolaus. The firm has “Buy” rating given on Thursday, October 29 by Stifel Nicolaus. The stock has “Hold” rating by Jefferies on Wednesday, January 20. The rating was maintained by Jefferies on Tuesday, May 30 with “Hold”. The firm earned “Buy” rating on Tuesday, January 2 by Longbow. The stock of The Timken Company (NYSE:TKR) earned “Market Perform” rating by Avondale on Monday, March 21.

More recent The Timken Company (NYSE:TKR) news were published by: Seekingalpha.com which released: “Timken Co. 2018 Q1 – Results – Earnings Call Slides” on May 01, 2018. Also Seekingalpha.com published the news titled: “The Timken (TKR) Q1 2018 Results – Earnings Call Transcript” on May 01, 2018. Globenewswire.com‘s news article titled: “Recent Analysis Shows Paycom Software, American Renal Associates, Knowles, Timken, Nevro, and Unisys Market …” with publication date: May 15, 2018 was also an interesting one.

First Trust Advisors Lp, which manages about $85.44B and $42.00 billion US Long portfolio, decreased its stake in Qualcomm Inc (NASDAQ:QCOM) by 322,056 shares to 3.07 million shares, valued at $196.23 million in 2017Q4, according to the filing. It also reduced its holding in Inc Resh Hldgs Inc (NASDAQ:INCR) by 88,779 shares in the quarter, leaving it with 6,889 shares, and cut its stake in Hub Group Inc (NASDAQ:HUBG).

Investors sentiment increased to 0.88 in 2017 Q4. Its up 0.23, from 0.65 in 2017Q3. It improved, as 25 investors sold TKR shares while 113 reduced holdings. 49 funds opened positions while 72 raised stakes. 59.34 million shares or 1.11% less from 60.00 million shares in 2017Q3 were reported. Visionary Asset Mgmt holds 0.09% or 6,700 shares in its portfolio. Security National Bank & Trust Of So Dak has invested 1.15% of its portfolio in The Timken Company (NYSE:TKR). Stephens Ar holds 9,514 shares or 0.02% of its portfolio. Art Advsrs Ltd accumulated 0.01% or 6,700 shares. Moreover, Mondrian Inv Ptnrs Ltd has 0.1% invested in The Timken Company (NYSE:TKR). Cadence Cap Mgmt Lc holds 9,956 shares or 0.03% of its portfolio. Virginia Retirement Sys Et Al reported 49,000 shares. 4,226 were reported by Ing Groep Nv. Liberty Mutual Asset Mngmt invested 0.03% of its portfolio in The Timken Company (NYSE:TKR). Alps Advisors holds 0% of its portfolio in The Timken Company (NYSE:TKR) for 5,815 shares. Virtus Investment Advisers Inc owns 8,207 shares. Kennedy reported 96,972 shares. Bessemer Group reported 7,500 shares. Deutsche Commercial Bank Ag holds 0.01% or 341,809 shares in its portfolio. 300 were reported by Whittier Comm Of Nevada Incorporated.

Since February 20, 2018, it had 1 buy, and 3 insider sales for $383,986 activity. WOODS JACQUELINE F also sold $151,152 worth of The Timken Company (NYSE:TKR) on Tuesday, February 20. 2,000 shares valued at $89,700 were bought by SULLIVAN FRANK C on Thursday, May 3. Fracassa Philip D. sold $178,388 worth of stock or 3,739 shares.

Korea Investment Corp, which manages about $21.97B US Long portfolio, decreased its stake in Allergan Plc by 30,078 shares to 242,186 shares, valued at $39.62 million in 2017Q4, according to the filing. It also reduced its holding in Leucadia Natl Corp (NYSE:LUK) by 16,800 shares in the quarter, leaving it with 136,800 shares, and cut its stake in Hologic Inc (NASDAQ:HOLX).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson Sells Off After Earnings” on April 22, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Consumer and Medical Devices Business Review – Brokers Conference Transcript” published on May 17, 2018, Seekingalpha.com published: “Johnson & Johnson: Waiting On The Wave” on May 11, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” published on May 02, 2018 as well as Livetradingnews.com‘s news article titled: “Johnson & Johnson (NYSE:JNJ) Stock Oversold” with publication date: May 03, 2018.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Sentinel Trust Lba has 7,765 shares. Reilly Fincl Advisors Ltd reported 94,163 shares. Moreover, Cornerstone Inv Prns Ltd Limited Liability Company has 4.6% invested in Johnson & Johnson (NYSE:JNJ). Wall Street Access Asset Mngmt Lc owns 6,243 shares. Cincinnati Casualty reported 25,000 shares. Carroll Fin Inc owns 1.12% invested in Johnson & Johnson (NYSE:JNJ) for 73,128 shares. Family Mgmt accumulated 32,337 shares. Sol Capital Mgmt Comm accumulated 10,924 shares. Baker Boyer Natl Bank has invested 4% in Johnson & Johnson (NYSE:JNJ). Old Dominion Capital Mngmt holds 0.83% or 6,158 shares. Gemmer Asset Management Lc owns 14,483 shares. The North Carolina-based Hamilton Point Advsr Lc has invested 2.49% in Johnson & Johnson (NYSE:JNJ). Raab And Moskowitz Asset Mngmt Ltd Liability reported 40,383 shares stake. Nichols And Pratt Advisers Limited Liability Partnership Ma owns 710,318 shares. Cornerstone Advisors, a Alabama-based fund reported 132,700 shares.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: